Brief: U.S. Renal Care Enrolls First Patients In The Voice Collaborative Clinical Trial Of Vafseo® (Vadadustat) For CKD Patients On Dialysis
03/12/2024 12:15
Dec 3 (Reuters) - Akebia Therapeutics AKBA.O :
* U.S. RENAL CARE ENROLLED FIRST PATIENTS IN THE VOICE
COLLABORATIVE CLINICAL TRIAL OF VAFSEO® (VADADUSTAT) FOR CKD
PATIENTS ON DIALYSIS
* AKEBIA THERAPEUTICS INC - VAFSEO EXPECTED TO BE AVAILABLE
IN
U.S. IN JANUARY 2025
Source text: ID:nPn7Xv2nXa
Further company coverage: AKBA.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Akebia Therapeutics
See all newsAkebia Q1 revenue falls, net income misses analyst estimates on higher expenses
Brief: Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
Brief: Akebia Therapeutics Appoints Biopharmaceutical Leader Philip Vickers To Its Board Of Directors
Akebia posts wider-than-expected Q4 net loss as higher expenses hurt
Brief: Akebia Therapeutics Reports Inducement Grants Under Nasdaq Listing Rule